Yeter et al. reported aplastic anemia within 4 weeks of AZA therapy, which resulted in death unrelated to abnormal TPMT activity in a young woman with systemic lupus erythematosus [15]. This evidence concerns the gene TPMT and systemic lupus erythematosus.